Skip to main content

Table 4 Mean changes (SD) of metabolic characteristics in the two study groups

From: The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial

Change from baselineFlaxseed group (n = 21)Control group (n = 20)P1P2
Weight (kg)−0.9 ± 1.890.91 ± 1.580.001a0.006a
Waist circumference (cm)−1.95 ± 1.650.58 ± 3.320.007a0.004a
BMI (kg/m2)−0.38 ± 0.760.36 ± 0.620.001a0.003a
FBS (mg/dL)−6.95 ± 20.76−2.22 ± 16.960.450.023a
Insulin (μIU/mL)−2.75 ± 4.061.52 ± 6.740.021a0.007a
HOMA-IR−0.72 ± 1.130.26 ± 1.610.034a0.009a
QUICKI0.01 ± 0.02− 0.004 ± 0.020.050.006a
Total cholesterol (mg/dL)−8.3 ± 34.89−14.11 ± 36.330.6180.871
LDL-cholesterol (mg/dL)−13.18 ± 39−11.61 ± 41.540.9050.665
HDL-cholesterol (mg/dL)9.25 ± 6.59−2.77 ± 10.68P < 0.001aP < 0.001a
Triglycerides (mg/dL)−21.85 ± 22.06− 0.27 ± 28.810.013a0.011a
Total testosterone (ng/mL)0.03 ± 0.350.07 ± 0.290.6940.866
SHBG (nmol/L)6.76 ± 30.366.35 ± 18.170.9590.051
FAI−0.73 ± 1.23−0.13 ± 1.480.2480.046a
mF-G scores−1.09 ± 2.9− 0.36 ± 3.110.1210.254
hs-CRP (mg/L)− 1.32 ± 2.08−0.24 ± 1.930.1080.011a
IL-6 (pg/mL)0.62 ± 2.220.89 ± 2.580.7310.237
Adiponectin (mg/mL)4.31 ± 5.53−0.39 ± 6.020.017a0.041a
Leptin (ng/ml)−9.48 ± 14.559.7 ± 25.930.007a0.006a
  1. The data have been expressed as mean ± SD. P1: between-group comparison of the mean changes of the studied variables; Mann–Whitney U (for waist circumference, insulin, QUICKI, and Ferriman-Gallwey score) and independent sample t-test (for other variables). P2: between-group comparison of the mean changes of the studied variables; analysis of covariance in the adjusted models (adjusted for age, BMI, dietary intake of energy, physical activity, and baseline biochemical variables)
  2. aStatistically significant